My Quote Request
No products added yet
6505-01-262-4974
20 Products
TRANXENE T-TAB
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
TRANXENE T-TAB
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION
Related Searches:
NDC00009-0010-22
TRIAZOLAM TABLETS,USP
NSN, MFG P/N
6505012622177
NSN
6505-01-262-2177
NDC00009-0010-22
TRIAZOLAM TABLETS,USP
NSN, MFG P/N
6505012622177
NSN
6505-01-262-2177
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.125 MILLIGRAMS TRIAZOLAM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIAZOLAM TABLETS USP 0.125MG I.S. 100S
PRIMARY CONTAINER TYPE: STRIP
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: 100 TABLETS
Related Searches:
5505-062
IOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM,USP
NSN, MFG P/N
6505012622300
NSN
6505-01-262-2300
5505-062
IOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM,USP
NSN, MFG P/N
6505012622300
NSN
6505-01-262-2300
MFG
MALLINCKRODT SPECIALTY CHEMICALS CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 39.300 PER CENTAGE W/V IOXAGLATE MEGLUMINE ACTIVE INGREDIENT AND 19.600 PERCENTAGE W/V IOXAGLATE SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM USP 50ML VIAL 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
HEXABRIX
IOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM,USP
NSN, MFG P/N
6505012622300
NSN
6505-01-262-2300
HEXABRIX
IOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM,USP
NSN, MFG P/N
6505012622300
NSN
6505-01-262-2300
MFG
MALLINCKRODT SPECIALTY CHEMICALS CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 39.300 PER CENTAGE W/V IOXAGLATE MEGLUMINE ACTIVE INGREDIENT AND 19.600 PERCENTAGE W/V IOXAGLATE SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM USP 50ML VIAL 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00019-5505-06
IOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM,USP
NSN, MFG P/N
6505012622300
NSN
6505-01-262-2300
NDC00019-5505-06
IOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM,USP
NSN, MFG P/N
6505012622300
NSN
6505-01-262-2300
MFG
MALLINCKRODT SPECIALTY CHEMICALS CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 39.300 PER CENTAGE W/V IOXAGLATE MEGLUMINE ACTIVE INGREDIENT AND 19.600 PERCENTAGE W/V IOXAGLATE SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM USP 50ML VIAL 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
CEFOTAN
CEFOTETAN DISODIUM,USP
NSN, MFG P/N
6505012622698
NSN
6505-01-262-2698
MFG
ZENECA INC ZENECA PHARMACEUTICALS GROUP STUART PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS CEFOTETAN EQUIVALENT
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 20 ML VIALS
Related Searches:
NDC00038-0377-20
CEFOTETAN DISODIUM,USP
NSN, MFG P/N
6505012622698
NSN
6505-01-262-2698
NDC00038-0377-20
CEFOTETAN DISODIUM,USP
NSN, MFG P/N
6505012622698
NSN
6505-01-262-2698
MFG
ZENECA INC ZENECA PHARMACEUTICALS GROUP STUART PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS CEFOTETAN EQUIVALENT
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 20 ML VIALS
Related Searches:
402
POVIDONE-IODINE CLEANSING SOLUTION,USP
NSN, MFG P/N
6505012624547
NSN
6505-01-262-4547
402
POVIDONE-IODINE CLEANSING SOLUTION,USP
NSN, MFG P/N
6505012624547
NSN
6505-01-262-4547
MFG
KIMBERLY-CLARK CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.750 PERCENTAGE, W/V POVIDONE-IODINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POVIDONE-IODINE CLEANSING SOLUTION USP 1LI BOTTLE 12S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BALLARD MEDICAL PRODUCTS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 LITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
FOAM CARE
POVIDONE-IODINE CLEANSING SOLUTION,USP
NSN, MFG P/N
6505012624547
NSN
6505-01-262-4547
FOAM CARE
POVIDONE-IODINE CLEANSING SOLUTION,USP
NSN, MFG P/N
6505012624547
NSN
6505-01-262-4547
MFG
KIMBERLY-CLARK CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.750 PERCENTAGE, W/V POVIDONE-IODINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POVIDONE-IODINE CLEANSING SOLUTION USP 1LI BOTTLE 12S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BALLARD MEDICAL PRODUCTS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 LITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00005-3434-23
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
NDC00005-3434-23
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION
Related Searches:
NDC00047-0451-24
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
NDC00047-0451-24
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
MFG
CORBETT BROS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION
Related Searches:
NDC00074-4389-13
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
NDC00074-4389-13
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION
Related Searches:
NDC00228-3067-11
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
NDC00228-3067-11
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
MFG
ACTAVIS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION
Related Searches:
NDC00364-2201-01
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
NDC00364-2201-01
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
MFG
SCHEIN HENRY INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION
Related Searches:
NDC00378-0030-01
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
NDC00378-0030-01
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
MFG
MYLAN PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION
Related Searches:
NDC00536-4940-01
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
NDC00536-4940-01
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
MFG
RUGBY GROUP INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION
Related Searches:
NDC00591-0363-01
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
NDC00591-0363-01
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
MFG
DANBURY PHARMACAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION
Related Searches:
NDC53265-0048-10
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
NDC53265-0048-10
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
MFG
ABLE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION
Related Searches:
NDC67386-0301-01
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
NDC67386-0301-01
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
MFG
OVATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION
Related Searches:
TRANXENE
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
TRANXENE
CLORAZEPATE DIPOTASSIUM TABLETS,USP
NSN, MFG P/N
6505012624974
NSN
6505-01-262-4974
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION
